MACROGENICS, INC. Other Current Liabilities
MACROGENICS, INC. (MGNX) had Other Current Liabilities of $175.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2019-11-06
- 2019-09-30: Other Liabilities, Current $175.00K.
- 2019-06-30: Other Liabilities, Current $175.00K.
- 2019-03-31: Other Liabilities, Current $175.00K.
- 2018-12-31: Other Liabilities, Current $175.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2019-09-30 | $175.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $175.00K 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $175.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $175.00K 10-Q · filed 2019-11-06 | |
| 2018-09-30 | $175.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $175.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $175.00K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $473.00K 10-K · filed 2019-02-26 | $175.00K 10-K · filed 2018-02-27 |
| 2017-09-30 | $175.00K 10-Q · filed 2017-11-08 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $727.00K 10-K · filed 2017-02-28 | |
| 2015-09-30 | $1.60M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $1.60M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $1.60M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $1.60M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $363.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $363.00K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $362.92K 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $363.00K 10-K · filed 2015-03-03 | $362.92K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |